HI. Agree (and thanks for highlighting the details).All pieces...

First 17 Last

Share
Profile

Follow
disaster

252 Posts.

45

19/01/23

06:51

Post #: 65763983
Share

Originally posted by Eire2011: ↑

Hi Disaster,

From the report you shared.

“The investigators concluded that approximately one-third of patients undergoing TAVR failed to improve their exercise capacity after the procedure. The lack of functional improvement after TAVR was predicted by a mix of baseline and periprocedural factors translating into poorer clinical outcomes.”

Plus, this is a 6 month report and after that typically patients get worse not better. Ours improved a further 17% from 30 days to 12 months! Not to mention that some of our patients were older and actually on their death bed. One patient had 2 to 3 weeks to live and now has normal valve function. Amazing.

I think this is keeping it real.

Expand

HI. Agree (and thanks for highlighting the details).
All pieces of the Puzzle.

Showing results in a very complicated patient population not seen otherwise is a huge achievement for them and the reputation of the product.

AVR Price at posting: $26.10 Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PTX

Prescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trial

Expert Exchange: It's half time Down Under – How are we faring?

First 17 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $6.08		Change -0.040(0.65%)		Mkt cap ! $94.85M

Open	High	Low	Value	Volume
$6.01	$6.08	$6.01	$9.92K	1.65K

Buyers (Bids)

No.	Vol.	Price($)
2	1624	$6.00

Sellers (Offers)

Price($)	Vol.	No.
$6.07	190	1

View Market Depth

No.	Vol.	Price($)
2	1624	6.000
2	878	5.860
2	195	5.850
1	857	5.830
1	900	5.780

Price($)	Vol.	No.
6.080	450	2
6.150	2710	2
6.180	50	1
6.200	1000	1
6.400	130	1

Last trade - 11.13am 26/06/2025 (20 minute delay)

AVR (ASX) Chart

HI. Agree (and thanks for highlighting the details).All pieces...

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Australia’s gas crisis is here – and dying coal plants aren’t helping

Prescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trial

Expert Exchange: It's half time Down Under – How are we faring?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

HI. Agree (and thanks for highlighting the details).All pieces...

Top Stories

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Australia’s gas crisis is here – and dying coal plants aren’t helping

Prescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trial

Expert Exchange: It's half time Down Under – How are we faring?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News